Key statistics
As of last trade AxoGen Inc (LT3:FRA) traded at 12.40, -13.29% below its 52-week high of 14.30, set on Nov 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.40 |
---|---|
High | 12.40 |
Low | 12.40 |
Bid | 12.70 |
Offer | 13.00 |
Previous close | 12.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 44.01m |
Free float | 41.57m |
P/E (TTM) | -- |
Market cap | 576.51m USD |
EPS (TTM) | -0.3302 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:11 GMT.
More ▼
Announcements
- Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
- Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
- Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
- Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
- Axogen, Inc. Announces New Leadership Appointments
- Axogen, Inc. Reports Second Quarter 2024 Financial Results
- Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
- Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
- Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
- Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
More ▼